The store will not work correctly when cookies are disabled.
N-(5-iodo-6-methylpyridin-2-yl)-1,5-naphthyridine-3-carboxamide
ID: ALA4090807
PubChem CID: 137643279
Max Phase: Preclinical
Molecular Formula: C15H11IN4O
Molecular Weight: 390.18
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nc(NC(=O)c2cnc3cccnc3c2)ccc1I
Standard InChI: InChI=1S/C15H11IN4O/c1-9-11(16)4-5-14(19-9)20-15(21)10-7-13-12(18-8-10)3-2-6-17-13/h2-8H,1H3,(H,19,20,21)
Standard InChI Key: QLAZOAIYIFHPQU-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
3.6771 -2.7927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3867 -2.3832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3839 -1.5606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6753 -1.1553 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0951 -2.7907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0964 -3.6079 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8022 -2.3810 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5105 -2.7885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5072 -3.6041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2147 -4.0116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9227 -3.6018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9188 -2.7804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2107 -2.3767 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6244 -2.3682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6316 -4.0083 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
2.9690 -2.3837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9713 -1.5618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2618 -1.1507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5496 -1.5603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5512 -2.3853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2613 -2.7928 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 17 1 0
2 5 1 0
5 6 2 0
5 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
12 14 1 0
11 15 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 16 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 390.18 | Molecular Weight (Monoisotopic): 389.9978 | AlogP: 3.19 | #Rotatable Bonds: 2 |
Polar Surface Area: 67.77 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.56 | CX Basic pKa: 1.99 | CX LogP: 2.83 | CX LogD: 2.83 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.68 | Np Likeness Score: -2.00 |
References
1. Siddiqui-Jain A, Hoj JP, Hargiss JB, Hoj TH, Payne CJ, Ritchie CA, Herron SR, Quinn C, Schuler JT, Hansen MDH.. (2017) Pyridine-pyrimidine amides that prevent HGF-induced epithelial scattering by two distinct mechanisms., 27 (17): [PMID:28780159] [10.1016/j.bmcl.2017.07.063] |